Interplay between LPA2 and LPA3 in LPA-mediated phosphatidylserine cell surface exposure and extracellular vesicles release by erythrocytes
Open Access
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 192, 114667
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (MOP-142210)
This publication has 55 references indexed in Scilit:
- Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIaJournal of Thrombosis and Haemostasis, 2012
- Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritisJournal of Experimental Medicine, 2012
- TNF-α promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokinesJournal of Lipid Research, 2011
- The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulationJournal of Lipid Research, 2011
- Aiming drug discovery at lysophosphatidic acid targetsBritish Journal of Pharmacology, 2010
- Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet ActivationJournal of Biological Chemistry, 2009
- Erythrocyte vesiculation: a self‐protective mechanism?British Journal of Haematology, 2008
- Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during DevelopmentMolecular and Cellular Biology, 2006
- Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA speciesFEBS Letters, 2000
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994